Federal Register Notice: FDA is announcing the fee rate at $2,562,000 for using a rare pediatric disease priority review voucher for fiscal year 2015. These vouchers are awarded to the sponsors of certain rare pediatric disease product applications for human drug or biological products, submitted 90 days or more after 7/9/12 upon FDA approval of such applications. To view this notice, click here.
